ProQR Therapeutics (PRQR) Total Liabilities (2013 - 2025)

ProQR Therapeutics' Total Liabilities history runs 13 years deep, the most recent figure standing at $73.8 million for Q4 2025.

• In Q4 2025, Total Liabilities fell 13.04% year-over-year to $73.8 million; the TTM figure through Dec 2025 stood at $73.8 million (down 13.04% YoY), while the FY2025 annual figure was $73.8 million, down 13.04% from the prior year.
• Total Liabilities came in at $73.8 million for Q4 2025 at ProQR Therapeutics, down from $84.8 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $51.2 billion in Q1 2021 to a low of $54.0 million in Q2 2021.
• A 5-year average of $3.7 billion and a median of $102.4 million in 2022 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities jumped 207944.81% in 2021 and slumped 99.8% in 2022, its largest moves.
• ProQR Therapeutics' Total Liabilities stood at $110.2 million in 2021, then dropped by 3.14% to $106.8 million in 2022, then decreased by 2.75% to $103.8 million in 2023, then slipped by 18.28% to $84.8 million in 2024, then dropped by 13.04% to $73.8 million in 2025.
• According to Business Quant data, Total Liabilities over the past three periods registered $73.8 million, $84.8 million, and $103.8 million for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison